Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society - Archive ouverte HAL Access content directly
Journal Articles Multiple Sclerosis Journal Year : 2022

Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society

(1) , (2) , (3) , (4) , , (5) , , (6) , (7) , (8) , (9, 10) , (11, 12, 13, 14, 15) , , (16) , , , , , , (17) , , , , , , , , , (18) , , , , , , (19) , (20)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
Romain Marignier
Bertrand Bourre
  • Function : Author
Mikael Cohen
Maxime Guillaume
  • Function : Author
Clarisse Carra-Dalliere
Anne-Marie Guennoc
  • Function : Author
Géraldine Androdias
  • Function : Author
Caroline Bensa
  • Function : Author
Kevin Bigaut
Damien Biotti
Pierre Branger
  • Function : Author
Elodie Daval
  • Function : Author
Cécile Donze
  • Function : Author
Anne-Laure Dubessy
  • Function : Author
Arnaud Kwiatkowski
  • Function : Author
Cécile Dulau
  • Function : Author
Françoise Durand-Dubief
  • Function : Author
Benjamin Hebant
  • Function : Author
Julien Lannoy
  • Function : Author
Eric Manchon
  • Function : Author
Guillaume Mathey
  • Function : Author
Xavier Moisset
Alexis Montcuquet
  • Function : Author
Thomas Roux
Elisabeth Maillart

Abstract

Background: In 2020, the French Multiple Sclerosis (MS) Society (SFSEP) decided to develop a national evidence-based consensus on pregnancy in MS. As neuromyelitis optica spectrum disorders (NMOSD) shares a series of commonalities with MS, but also some significant differences, specific recommendations had to be developed. Objectives: To establish recommendations on pregnancy in women with NMOSD. Methods: The French Group for Recommendations in Multiple Sclerosis (France4MS) reviewed PubMed and universities databases (January 1975 through June 2021). The RAND/UCLA appropriateness method, which was developed to synthesise the scientific literature and expert opinions on health care topics, was used to reach a formal agreement. Fifty-six MS experts worked on the full-text review and initial wording of recommendations. A sub-group of nine NMOSD experts was dedicated to analysing available data on NMOSD. A group of 62 multidisciplinary healthcare specialists validated the final proposal of summarised evidence. Results: A strong agreement was reached for all 66 proposed recommendations. They cover diverse topics, such as pregnancy planning, follow-up during pregnancy and postpartum, delivery routes, loco-regional analgesia or anaesthesia, prevention of postpartum relapses, breastfeeding, vaccinations, reproductive assistance, management of relapses, and disease-modifying treatments. Conclusion: Physicians and patients should be aware of the new and specific evidence-based recommendations of the French MS Society for pregnancy in women with NMOSD. They should help harmonise counselling and treatment practise, allowing for better individualised choices.
Not file

Dates and versions

hal-03871563 , version 1 (25-11-2022)

Identifiers

Cite

Sandra Vukusic, Romain Marignier, Jonathan Ciron, Bertrand Bourre, Mikael Cohen, et al.. Pregnancy and neuromyelitis optica spectrum disorders: 2022 recommendations from the French Multiple Sclerosis Society. Multiple Sclerosis Journal, 2022, pp.135245852211309. ⟨10.1177/13524585221130934⟩. ⟨hal-03871563⟩
0 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More